Drug Discovery AI Talk

About Drug Discovery AI Talk

Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews

Publisher

Dr. Jake Chen

Category

news

Language

en

Explicit

No

First episode

22 Apr 2025

Latest episode

23 Oct 2026

Latest episodes

79 episodes in the feed.

1. 

   23 Oct 2026

   #79. Can AI Drug the Undruggable?

   Three fresh stories, one question: what happens when AI stops needing a protein's 3D shape and starts working with biology as it actually behaves? A virtual cell trained on proteins rather than genes predicts how cancer cells respond to drugs hour by hour. A new structure-free model finds drug binding sites on disordered proteins that no structure-based method can touch. And the first drug with both an AI-identified target and an AI-designed molecule has dosed its first Phase III patient. We walk through what each result actually shows, and what it doesn't. Produced by Dr. Jake Chen.

2. 

   16 Oct 2026

   #78. From Too Few to Too Many

   AI can now generate millions of molecules, thousands of drug targets, and entire scientific manuscripts in hours — but our capacity to validate any of it hasn't kept pace. This episode walks through the trust crisis in AI drug discovery: from ultra-large virtual screening libraries to AI-generated papers arriving faster than peer review can handle, from citation errors in machine-written manuscripts to the clinical programs that give real reason for optimism. The central question is no longer whether AI can generate drug candidates, but whether it can reliably improve therapeutic decisions — and why trustworthy evidence must become the industry's most valuable asset. Produced by Dr. Jake Chen.

3. 

   9 Oct 2026

   Virtual Biology's Reality Check

   Biohub's Virtual Biology Initiative just expanded to $1.8 billion — backed by the DOE, NIH, Google DeepMind, Isomorphic Labs, and Meta — to build the data foundations for predictive AI in biology. But a new perspective argues the field is celebrating too early: today's biological data are sparse across the spatial, temporal, and causal dimensions that actually determine how cells respond to drugs. This episode walks through why virtual cells are not digital twins, where the models could genuinely accelerate drug discovery first, and the validation ladder that separates credible prediction from hype. Produced by Dr. Jake Chen.

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

3 ratings

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 42 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

71

Social presence

0

YouTube

0

Engagement

32

Shows with a similar audience

• 

  BioCentury This Week

• 

  The Readout Loud

• 

  Lenny's Podcast: Product | Growth | Career

• 

  All-In with Chamath, Jason, Sacks & Friedberg

• 

  Biotech Business with Fexingo: Life Sciences Startups, Drug Discovery, and FDA Approvals

• 

  Huberman Lab